Comparing Paracetamol and Ibuprofen Safety in Infant Care

Desinformación en salud: un desafío estructural que exige una estrategia transversal

Drugs associated the most with Retroperitoneal Fibrosis: assessment of the 1969-2025 Food and Drug Administration (FDA) pharmacovigilance database

Good News for Patients Worried About Statin Side Effects: Study Finds Most Never Happen

Statin safety: when warnings outlive the evidence

EMA recommends withdrawal of marketing authorisations for levamisole medicines

The ASCEND Project (2020-2023): Strengthening clinical trial ethics review and pharmacovigilance capacity in Tanzania mainland and Zanzibar

AI-Enabled Surveillance and Modelling for Counterfeit Botulinum Toxin A: Risk Projection, Patient Safety, and Systemic Reform of Pharmacovigilance

Development and validation of a machine learning stratified prediction model for early warning of anti-tuberculosis drug-induced liver injury risk based on real-world data: a retrospective cohort study

20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys

Efficacy and safety of different inhaler types for asthma and chronic obstructive pulmonary disease. a systematic review and meta-analysis

Biochemical profiling provides a low-cost and globally accessible method to detect falsified vaccines and insulin

A framework for enhancing pharmaceutical integrity and patient safety: novel mobile health solution integrating smart packaging and computer vision

Drugs Associated with Pediatric Cataracts: A Real-World Pharmacovigilance Study

El Hospital Regional de Málaga alerta del reto del Paracetamol entre menores, que puede causar la muerte

A Review Harnessing Artificial Intelligence for Enhanced Pharmacovigilance

A Short Overview of Using Artificial Intelligence in Pharmacovigilance

Analysis of the Adverse Event Profiles of Medications for Alcohol Use Disorder: Insights from a Japanese Pharmacovigilance Database

Early Detection of Absurdity Signals in Pharmacovigilance: A Machine Learning Ensemble Approach to Identify Rare Adverse Drug Reactions

Artificial intelligence-based incident analysis and learning system to enhance patient safety and improve treatment quality

Further information on Post authorisation monitoring – Pharmacovigilance

Ministerio de Salud intensifica lucha frontal contra la falsificación de medicamentos

Drug-drug interaction, adverse drug reaction and their determinants among adult hypertensive patients; Multicenter study in Ethiopia

Age and Gender Heterogeneity in Adverse Drug Reactions Associated with Hemp Use: Evidence from the FDA Pharmacovigilance Data in the Last Two Decades

Artificial Intelligence and Machine Learning in Pharmacovigilance: A Systematic Review of Models for Drug Safety in Polypharmacy

Evaluating adverse events reported for non-steroidal anti-inflammatory drugs in osteoarthritis: a real-world pharmacovigilance study

Medication Concerns: Driving Factors in High-Risk Adults

La AEMPS informa del cambio de dosificación de Rybelsus (semaglutida) y los posibles errores de medicación

El CGCOF y la AEMPS lanzan una campaña para fomentar la notificación de reacciones adversas de los medicamentos

Safety population size and duration of exposure prior to approval of new medicines: A database analysis of medicines centralised approved in the European Union between 2011 and 2023

Veterinary drug residues in food: what’s the latest in the EU?

 

IXCHIQ Chikungunya vaccine: updates to restrictions of use following safety review

Las especialistas en Farmacología Clínica, claves para garantizar la seguridad de los medicamentos y la equidad en los ensayos clínicos

What drugs are safe during pregnancy? There’s a shocking lack of data

Impact of the amended CIR 520/2012 to UK authorised products

Updates to CIR 520/2012 – Information for UK Marketing Authorisation Holders

Clinicians and pharmacists – Are your patients aware of the risks of buying melatonin online?

Europa se estanca en la reducción de residuos de medicamentos veterinarios: más controles, pero mismos resultados

EsSalud refuerza la vigilancia de medicamentos y dispositivos médicos para prevenir riesgos en pacientes

Phosphorescent supramolecular systems for medicine anticounterfeiting